Faculty Opinions recommendation of Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.

Author(s):  
Venu Menon ◽  
Bhuvnesh Aggarwal
Sign in / Sign up

Export Citation Format

Share Document